Tango Therapeutics (TNGX) Non-Current Assets (2020 - 2025)
Historic Non-Current Assets for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $46.4 million.
- Tango Therapeutics' Non-Current Assets fell 1016.09% to $46.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $193.7 million, marking a year-over-year decrease of 986.05%. This contributed to the annual value of $50.1 million for FY2024, which is 1049.46% down from last year.
- Per Tango Therapeutics' latest filing, its Non-Current Assets stood at $46.4 million for Q3 2025, which was down 1016.09% from $47.8 million recorded in Q2 2025.
- Tango Therapeutics' 5-year Non-Current Assets high stood at $166.8 million for Q2 2021, and its period low was $7.8 million during Q4 2021.
- Its 5-year average for Non-Current Assets is $57.2 million, with a median of $53.0 million in 2024.
- Data for Tango Therapeutics' Non-Current Assets shows a peak YoY increase of 68288.35% (in 2022) and a maximum YoY decrease of 9348.3% (in 2022) over the last 5 years.
- Tango Therapeutics' Non-Current Assets (Quarter) stood at $7.8 million in 2021, then skyrocketed by 682.88% to $61.2 million in 2022, then dropped by 8.45% to $56.0 million in 2023, then decreased by 10.49% to $50.1 million in 2024, then dropped by 7.56% to $46.4 million in 2025.
- Its last three reported values are $46.4 million in Q3 2025, $47.8 million for Q2 2025, and $49.4 million during Q1 2025.